Archive
Collaboration agreement The Company and Fluicell signed a collaboration agreement on September 2, 2025, to advance joint efforts in catheter development.
Ambusol secures exclusive global rights to fluicell’s microfluidic technology Ambusol AB (publ) has entered an exclusive global licensing and development agreement with Fluicell AB (publ), granting Ambusol worldwide rights to apply Fluicell’s microfluidic technology in cancer treatment. The partnership provides Ambusol with a unique platform for precise delivery of therapeutic compounds directly into tumors, initially […]